Is Otezla (apremilast) an immunosuppressant?
Otezla is used in psoriasis, psoriatic arthritis, and Behçet's Disease as it reduces inflammation
by regulating inflammatory mediators, produced by immune cells.
It does this by blocking an enzyme called phosphodiesterase-4 (PDE4) which modifies the inflammatory response by
- lowering inflammatory mediators
- increasing anti-inflammatory mediators.
This results in reduced inflammation and a reduction in symptoms.
Does Otezla lower immunity?
Otezla is thought to have a greater effect on innate immunity compared to adaptive immunity, with no effect on T-cell or B-cell expansion. This may explain why clinical studies show a lower risk of serious infection.
References
- Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity: https://www.sciencedirect.com/science/article/pii/S0898656814001909
- Psoriasis Pathogenesis and Treatment: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471628/
- Otezla Medication Information: https://www.drugs.com/pro/otezla.html
Read next
Related medical questions
- How much does Otezla cost?
- How to stop taking Otezla?
- Who makes Otezla and why is it so expensive?
- Does Otezla cause weight gain?
- Is Otezla a biologic? What is Otezla used for?
- Does Otezla cause depression?
- How long has Otezla been on the market?
- Is Otezla safe to take during pregnancy?
- What are the new drugs for plaque psoriasis?
- How long does it take for Otezla to work?
- What does Otezla do to the body?
Drug information
Related support groups
- Otezla (24 questions, 64 members)
- Apremilast (5 questions, 6 members)
- Psoriatic Arthritis (78 questions, 276 members)
- Plaque Psoriasis (81 questions, 69 members)
- Behcet's Disease (8 questions, 31 members)